Insider Transactions in Q4 2024 at Quest Diagnostics Inc (DGX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 29
2024
|
Michael E Prevoznik SVP & General Counsel |
SELL
Open market or private sale
|
Direct |
35,146
-24.8%
|
$5,693,652
$162.7 P/Share
|
|
Nov 29
2024
|
Michael E Prevoznik SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
35,146
+32.31%
|
$3,022,556
$86.63 P/Share
|
|
Nov 27
2024
|
Catherine T. Doherty EVP, Regional Businesses |
SELL
Open market or private sale
|
Direct |
33,103
-17.0%
|
$5,362,686
$162.64 P/Share
|
|
Nov 27
2024
|
Catherine T. Doherty EVP, Regional Businesses |
BUY
Exercise of conversion of derivative security
|
Direct |
33,103
+24.59%
|
$3,409,609
$103.57 P/Share
|
|
Nov 06
2024
|
Michael J Deppe SVP, Corp. Controller & CAO |
SELL
Open market or private sale
|
Direct |
18,755
-6.86%
|
$2,869,515
$153.82 P/Share
|
|
Nov 06
2024
|
Michael J Deppe SVP, Corp. Controller & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,755
+16.2%
|
$1,275,340
$68.84 P/Share
|
|
Oct 28
2024
|
Karthik Kuppusamy SVP, Clinical Solutions |
SELL
Open market or private sale
|
Direct |
1,775
-15.42%
|
$276,900
$156.92 P/Share
|
|
Oct 21
2024
|
Patrick Plewman SVP for Diagnostic Services |
BUY
Small Acquisition
|
Direct |
60
+0.37%
|
$8,940
$149.37 P/Share
|
|
Oct 21
2024
|
Karthik Kuppusamy SVP, Clinical Solutions |
BUY
Small Acquisition
|
Direct |
21
+0.18%
|
$3,129
$149.37 P/Share
|
|
Oct 21
2024
|
Sam Samad Executive Vice President & CFO |
BUY
Small Acquisition
|
Direct |
37
+0.21%
|
$5,513
$149.37 P/Share
|
|
Oct 21
2024
|
Mark E Delaney SVP & Chief Commercial Officer |
BUY
Small Acquisition
|
Direct |
4
+0.08%
|
$596
$149.39 P/Share
|
|
Oct 21
2024
|
Vicky B Gregg Director |
BUY
Small Acquisition
|
Direct |
76
+0.42%
|
$11,324
$149.37 P/Share
|